Post-marketing study to assess the risk of intussusception after immunization with GlaxoSmithKline (GSK) Biologicals’ oral live-attenuated human rotavirus vaccine in infants less than 1 year old in Latin America (212329)

06/08/2025
10/03/2026
EU PAS number:
EUPAS1000000701
Study
Ongoing
Data sources

Data source(s)

Data source(s), other

Medical records, parent(s)/legally acceptable representative (LAR[s]) interviews, vaccination cards and immunization registries.

Data sources (types)

Other
Spontaneous reports of suspected adverse drug reactions
Vaccination registry

Data sources (types), other

Medical records
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Yes

Check completeness

Yes

Check stability

Yes

Check logical consistency

Yes
Data characterisation

Data characterisation conducted

Yes